• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[子宫颈癌复发的外科治疗]

[Surgical treatment of recurrence of uterine cervix cancer].

作者信息

Dauplat J, Rodier J F, Issert B, Giraud B

出版信息

J Chir (Paris). 1986 Apr;123(4):251-4.

PMID:3745310
Abstract

Surgery for recurrence of malpighian epithelioma of uterine cervix was performed in 14 patients, exenteration being necessary in 10 cases (5 anterior, 4 total and 1 posterior). Possibilities of surgical excision of recurrences are limited (10 to 20% of cases) and should not be considered except after a careful general, local and regional investigation including, if necessary, and exploratory laparotomy. This recovery surgery must be preceded by high-dose irradiation. This partly explains the high incidence of exenterations, with the need for cutaneous bypass of urine and/or fecal matter, but also the high prevalence of postoperative complications and mortality. Long-term results are deceiving and a 5-year survival rate of 20% appears to be maximum obtainable. However, this surgery remains the only solution capable of providing the patients with a chance, and it very often relieves them of the painful course of a pelvic tumor.

摘要

对14例子宫颈马尔皮基上皮瘤复发患者实施了手术,其中10例(5例前盆腔脏器清除术、4例全盆腔脏器清除术和1例后盆腔脏器清除术)需要进行盆腔脏器清除术。复发病灶的手术切除可能性有限(占病例的10%至20%),除非在进行仔细的全身、局部和区域检查(必要时包括探查性剖腹术)之后,否则不应考虑手术切除。这种补救性手术必须在大剂量放疗之前进行。这部分解释了盆腔脏器清除术的高发生率,以及尿液和/或粪便的皮肤旁路需求,同时也解释了术后并发症和死亡率的高发生率。长期结果具有欺骗性,20%的5年生存率似乎是所能达到的最高值。然而,这种手术仍然是唯一能够为患者提供机会的解决方案,而且它常常能使患者摆脱盆腔肿瘤的痛苦病程。

相似文献

1
[Surgical treatment of recurrence of uterine cervix cancer].[子宫颈癌复发的外科治疗]
J Chir (Paris). 1986 Apr;123(4):251-4.
2
Indications for primary and secondary exenterations in patients with cervical cancer.宫颈癌患者原发和继发眼眶内容剜除术的适应症。
Gynecol Oncol. 2006 Dec;103(3):1023-30. doi: 10.1016/j.ygyno.2006.06.027. Epub 2006 Aug 4.
3
Pelvic exenteration for adenocarcinoma of the uterine cervix.子宫颈腺癌的盆腔脏器切除术
Gynecol Oncol. 1995 Jul;58(1):74-8. doi: 10.1006/gyno.1995.1186.
4
[Role of pelvic exenterations in the treatment of cervix cancers. Apropos of 41 surgically treated cases].盆腔脏器清除术在宫颈癌治疗中的作用。基于41例手术治疗病例
Chirurgie. 1994;120(8):409-14; 414-5.
5
The place for surgery in central recurrences of invasive cancer of cervix uteri.
Acta Chir Belg. 1995 Jan-Feb;95(1):38-43.
6
Surgically (laparotomy/laparoscopy) guided placement of high dose rate interstitial irradiation catheters (LG-HDRT): technique and outcome.手术(剖腹术/腹腔镜检查)引导下高剂量率组织间照射导管的放置(LG-HDRT):技术与结果
Gynecol Oncol. 2006 Jan;100(1):145-8. doi: 10.1016/j.ygyno.2005.08.055. Epub 2005 Oct 24.
7
[Repair surgery in the treatment of cancer of the cervical remnant].[修复手术治疗子宫颈残端癌]
Rev Fr Gynecol Obstet. 1991 Apr;86(4):336-40.
8
Neoadjuvant chemotherapy followed by radical surgery and radiotherapy vs. pelvic irradiation in patients with cervical cancer FIGO stage IIB - IVA.FIGO IIB-IVA期宫颈癌患者新辅助化疗后行根治性手术及放疗与盆腔放疗的对比研究
J BUON. 2006 Jul-Sep;11(3):291-7.
9
[Current status of frequency and complications of pelvic exenterations for recurrent cervico-uterine cancer after radiation].[放疗后复发性宫颈子宫癌盆腔脏器清除术的频率及并发症现状]
Ginecol Obstet Mex. 1996 Dec;64:538-43.
10
Therapeutic outcome and prognostic factors in the radiotherapy of recurrences of cervical carcinoma following surgery.宫颈癌术后复发放疗的治疗结果及预后因素
Strahlenther Onkol. 2003 Nov;179(11):742-7. doi: 10.1007/s00066-003-1100-6.